Fred Grossman

Insider Reports History

Entity
Individual
Location
C/O Coya Therapeutics, Inc., 5850 San Felipe St., Suite 500, Houston, TX
Signature
/s/ David Snyder, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fred Grossman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Coya Therapeutics, Inc. Chief Medical Officer Common Stock, par value $0.0001 per share 2.71K $20K $7.37 Nov 11, 2024 Direct
Coya Therapeutics, Inc. Chief Medical Officer Stock Option (right to buy) 70.6K Jun 3, 2024 Direct

Insider Reports Filed by Fred Grossman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
COYA Coya Therapeutics, Inc. Nov 11, 2024 1 $20K 4 Nov 12, 2024 Chief Medical Officer
COYA Coya Therapeutics, Inc. Jun 3, 2024 1 $0 4 Jun 5, 2024 Chief Medical Officer
COYA Coya Therapeutics, Inc. Jan 31, 2024 2 $0 4 Feb 2, 2024 Chief Medical Officer
COYA Coya Therapeutics, Inc. Jul 17, 2023 1 $0 4 Jul 19, 2023 Chief Medical Officer
COYA Coya Therapeutics, Inc. Jul 17, 2023 0 $0 3 Jul 19, 2023 Chief Medical Officer